Colon Polyps: Types, Pathology and Follow-Up
A colon polyp is a growth from the bowel lining, and most polyps are not cancer. Pathology separates conventional adenomas, serrated lesions, hyperplastic polyps and other findings because their future risk differs. Follow-up timing depends on the most important combination of type, size, number, dysplasia…
Timeline
- 2020-07-02: The U.S. Multi-Society Task Force published its consensus update on follow-up after colonoscopy and polypectomy.
- 2026-10-12: Current NCI, ACG and Multi-Society Task Force polyp guidance was reviewed for this guide.
A colon polyp is a growth projecting from or spreading along the lining of the colon or rectum. It can be pedunculated on a stalk or sessile and flatter against the wall. Most polyps are not cancer, and removing precancerous lesions is one reason colonoscopy can prevent colorectal cancer. Appearance and size help the endoscopist decide how to remove a lesion, but the final risk category often depends on microscopic examination by a pathologist. [1][4]
Conventional adenomas are common precancerous polyps. Pathology may call them tubular, tubulovillous or villous and may describe low-grade or high-grade dysplasia. “Dysplasia” means abnormal cellular development; it is not automatically invasive cancer. Larger size, greater number, villous features and high-grade dysplasia generally lead to closer surveillance because they are associated with higher future risk. The margin or completeness of removal matters as well, especially for a large lesion removed in pieces. [1][3][4]
Serrated polyps form another pathway. NCI divides them into hyperplastic polyps, sessile serrated polyps or lesions, and traditional serrated adenomas. Small hyperplastic polyps in the rectum or sigmoid usually carry low malignant potential, while sessile serrated lesions and traditional serrated adenomas can be precursors to cancer. Names have evolved—an “SSA,” “SSP” and “sessile serrated lesion” may refer to closely related terminology—so readers should use the pathologist’s exact wording and ask for clarification rather than grouping every serrated finding together. [2][3]
The surveillance interval is determined by the highest-risk relevant finding, not by the average of all polyps. Under the 2020 U.S. Multi-Society Task Force guidance, one or two tubular adenomas under 10 mm that are completely removed at a high-quality examination generally lead to repeat colonoscopy in seven to ten years. One or two sessile serrated polyps under 10 mm generally lead to five to ten years. Larger lesions, more numerous lesions, high-grade dysplasia or certain histology can shorten follow-up. These examples explain the framework; they are not a personal schedule. [3]
Quality conditions are part of every interval. The recommendations assume the colonoscope reached the cecum, bowel preparation was adequate to detect lesions larger than 5 mm, the examination was otherwise high quality and removal was complete. Poor preparation, uncertain excision or piecemeal removal can require earlier reassessment; the task force recommends six-month follow-up after piecemeal resection of an adenoma or sessile serrated lesion over 20 mm. A pathology label without the procedure report cannot establish whether those assumptions were met. [3]
Personal context can override an average-risk table. A history of colorectal cancer, inflammatory bowel disease, a hereditary syndrome, many cumulative adenomas or serrated polyposis, and some family histories require different strategies. Age, health, prior colonoscopies and whether the person could benefit from another procedure also matter. The endoscopist may wait for pathology before issuing the final interval, and findings at both the baseline and first surveillance colonoscopy can shape the next recommendation. [1][3][4]
Read the two reports together. The colonoscopy report supplies number, estimated size, location, morphology, preparation quality and removal method. The pathology report supplies tissue type, dysplasia and whether invasive cancer is present in the submitted specimen. Ask whether every lesion was retrieved, whether resection appeared complete and which finding controls follow-up. If the reports disagree on size or naming, the treating gastroenterologist and pathologist can reconcile the details; an internet label cannot substitute for that review. [1][3][4]
After polypectomy, follow the discharge instructions for bleeding, diet, activity and medicines. Small amounts of bleeding may be discussed in the instructions, but severe or persistent bleeding, worsening abdominal pain, fever, dizziness, fainting or a rigid swollen abdomen needs urgent medical assessment. Once pathology returns, record the exact recommended date and the assumptions behind it. A removed polyp is not the same as cancer, yet its type, size, number and removal quality provide useful evidence about the chance of future lesions and the timing of safe surveillance. [1][3][4]
Sources
- National Cancer Institute — Screening Tests to Detect Colorectal Cancer and Polyps
- National Cancer Institute Dictionary — Serrated Polyp
- American Gastroenterological Association — Follow-up After Colonoscopy and Polypectomy
- American College of Gastroenterology — Colon Polyps